Cleared Traditional

EURO TECH PLATINUM CHIROPRACTIC TABLE (K943975) - FDA 510(k) Clearance

Class I Physical Medicine device.

K943975 · Progressive Electrical Therapeutics · Physical Medicine device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1994
Decision
45d
Days
Class 1
Risk

K943975 is an FDA 510(k) clearance for the EURO TECH PLATINUM CHIROPRACTIC TABLE. Classified as Table, Mechanical (product code INW), Class I - General Controls.

Submitted by Progressive Electrical Therapeutics (Nevada, US). The FDA issued a Cleared decision on September 29, 1994 after a review of 45 days - a notably fast clearance cycle.

This device falls under the Physical Medicine FDA review panel, regulated under 21 CFR 890.3750 - the FDA physical medicine device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Progressive Electrical Therapeutics devices

Submission Details

510(k) Number K943975 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 1994
Decision Date September 29, 1994
Days to Decision 45 days
Submission Type Traditional
Review Panel Physical Medicine (PM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 115d · This submission: 45d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code INW Table, Mechanical
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 890.3750
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.